Liver Carcinoma — Trials

Liver Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

3,367 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 783
Recruiting: 463
Ph III recruiting: 41
Growth YoY: +1.5%
Industry share: 21%
Top sponsor: Sun Yat-sen University
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (386)

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07627191	GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer	recruiting	Early Phase 1	30	University of ArizonaOTHER	1	Sep 18, 2026	clinicaltrials
NCT07446257	THIO and Cadonilimab in Resectable Hepatocellular Carcinoma	recruiting	Early Phase 1	60	University of Texas Southwestern Medical CenterOTHER	1	Sep 3, 2026	clinicaltrials